MicroRNA-506-3p initiates mesenchymal-to-epithelial transition and suppresses autophagy in osteosarcoma cells by directly targeting SPHK1

References

• Lugowska I, Mierzejewska E, Lenarcik M, et al. The clinical significance of changes in ezrin expression in osteosarcoma of children and young adults. Tumour Biol. 2016;37(9):12071–12078.
   PubMedGoogle Scholar
• Zhang J, Lan Q, Lin J. Identification of key gene modules for human osteosarcoma by co-expression analysis. World J Surg Oncol. 2018;16(1):89.
   PubMedGoogle Scholar
• Faisham WI, Mat Saad AZ, Alsaigh LN, et al. Prognostic factors and survival rate of osteosarcoma: A single-institution study. Asia Pac J Clin Oncol. 2017;13(2):e104–e110.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2017. CA Cancer J Clin. 2017;67(1):7–30.
   PubMed Web of Science ®Google Scholar
• Tian B, Li X, Kalita M, et al. Analysis of the TGFbeta-induced program in primary airway epithelial cells shows essential role of NF-kappaB/RelA signaling network in type II epithelial mesenchymal transition. BMC Genomics. 2015;16:529.
   PubMed Web of Science ®Google Scholar
• Kalluri R. EMT: when epithelial cells decide to become mesenchymal-like cells. J Clin Invest. 2009;119(6):1417–1419.
   PubMed Web of Science ®Google Scholar
• Acloque H, Adams MS, Fishwick K, et al. Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease. J Clin Invest. 2009;119(6):1438–1449.
   PubMed Web of Science ®Google Scholar
• Jiang J, Tang YL, Liang XH. EMT: a new vision of hypoxia promoting cancer progression. Cancer Biol Ther. 2011;11(8):714–723.
   PubMed Web of Science ®Google Scholar
• Bonavida B. Linking autophagy and the dysregulated NFkappaB/SNAIL/YY1/RKIP/PTEN loop in cancer: therapeutic implications. Crit Rev Oncog. 2018;23(5–6):307–320.
   PubMedGoogle Scholar
• Gugnoni M, Sancisi V, Manzotti G, et al. Autophagy and epithelial-mesenchymal transition: an intricate interplay in cancer. Cell Death Dis. 2016;7(12):e2520.
   PubMedGoogle Scholar
• Gabra MM, Salmena L. microRNAs and acute myeloid leukemia chemoresistance: a mechanistic overview. Front Oncol. 2017;7:255.
   PubMed Web of Science ®Google Scholar
• Yang D, Sun Y, Hu L, et al. Integrated analyses identify a master microRNA regulatory network for the mesenchymal subtype in serous ovarian cancer. Cancer Cell. 2013;23(2):186–199.
   PubMed Web of Science ®Google Scholar
• Arora H, Qureshi R, Park WY. miR-506 regulates epithelial mesenchymal transition in breast cancer cell lines. PLoS One. 2013;8(5):e64273.
   PubMed Web of Science ®Google Scholar
• Sakimura S, Sugimachi K, Kurashige J, et al. The miR-506-induced epithelial-mesenchymal transition is involved in poor prognosis for patients with gastric cancer. Ann Surg Oncol. 2015;22(Suppl 3):S1436–43.
   PubMedGoogle Scholar
• Jiashi W, Chuang Q, Zhenjun Z, et al. MicroRNA-506-3p inhibits osteosarcoma cell proliferation and metastasis by suppressing RAB3D expression. Aging (Albany NY). 2018;10(6):1294–1305.
   PubMedGoogle Scholar
• Yu Z, Zhang Y, Gao N, et al. Overexpression of miR-506 inhibits growth of osteosarcoma through Snail2. Am J Transl Res. 2015;7(12):2716–2723.
   PubMed Web of Science ®Google Scholar
• Shida D, Takabe K, Kapitonov D, et al. Targeting SphK1 as a new strategy against cancer. Curr Drug Targets. 2008;9(8):662–673.
   PubMed Web of Science ®Google Scholar
• Liu H, Ma Y, He HW, et al. SPHK1 (sphingosine kinase 1) induces epithelial-mesenchymal transition by promoting the autophagy-linked lysosomal degradation of CDH1/E-cadherin in hepatoma cells. Autophagy. 2017;13(5):900–913.
   PubMed Web of Science ®Google Scholar
• Hamada M, Kameyama H, Iwai S, et al. Induction of autophagy by sphingosine kinase 1 inhibitor PF-543 in head and neck squamous cell carcinoma cells. Cell Death Discov. 2017;3:17047.
   PubMedGoogle Scholar
• Li J, Yang B, Zhou Q, et al. Autophagy promotes hepatocellular carcinoma cell invasion through activation of epithelial-mesenchymal transition. Carcinogenesis. 2013;34(6):1343–1351.
   PubMedGoogle Scholar
• Su Z, Li G, Liu C, et al. Autophagy inhibition impairs the epithelial-mesenchymal transition and enhances cisplatin sensitivity in nasopharyngeal carcinoma. Oncol Lett. 2017;13(6):4147–4154.
   PubMed Web of Science ®Google Scholar
• Streicher KL, Zhu W, Lehmann KP, et al. A novel oncogenic role for the miRNA-506-514 cluster in initiating melanocyte transformation and promoting melanoma growth. Oncogene. 2012;31(12):1558–1570.
   PubMed Web of Science ®Google Scholar
• Li J, Wu H, Li W, et al. Downregulated miR-506 expression facilitates pancreatic cancer progression and chemoresistance via SPHK1/Akt/NF-kappaB signaling. Oncogene. 2016;35(42):5501–5514.
   PubMed Web of Science ®Google Scholar
• Xu C, Zhang W, Liu S, et al. Activation of the SphK1/ERK/p-ERK pathway promotes autophagy in colon cancer cells. Oncol Lett. 2018;15(6):9719–9724.
   PubMed Web of Science ®Google Scholar
• Wang F, Wu Z. Sphingosine kinase 1 overexpression is associated with poor prognosis and oxaliplatin resistance in hepatocellular carcinoma. Exp Ther Med. 2018;15(6):5371–5376.
   PubMed Web of Science ®Google Scholar
• Yuza K, Nagahashi M, Shimada Y, et al. Upregulation of phosphorylated sphingosine kinase 1 expression in colitis-associated cancer. J Surg Res. 2018;231:323–330.
   PubMed Web of Science ®Google Scholar
• Akalay I, Janji B, Hasmim M, et al. Epithelial-to-mesenchymal transition and autophagy induction in breast carcinoma promote escape from T-cell-mediated lysis. Cancer Res. 2013;73(8):2418–2427.
   PubMed Web of Science ®Google Scholar
• Wu L, Chen Z, Xing Y. MiR-506-3p inhibits cell proliferation, induces cell cycle arrest and apoptosis in retinoblastoma by directly targeting NEK6. Cell Biol Int. 2018.
   Google Scholar
• Luo Y, Sun R, Zhang J, et al. miR-506 inhibits the proliferation and invasion by targeting IGF2BP1 in glioblastoma. Am J Transl Res. 2015;7(10):2007–2014.
   PubMed Web of Science ®Google Scholar
• Aparicio LA, Blanco M, Castosa R, et al. Clinical implications of epithelial cell plasticity in cancer progression. Cancer Lett. 2015;366(1):1–10.
   PubMed Web of Science ®Google Scholar
• Xu D, Liu S, Zhang L, et al. MiR-211 inhibits invasion and epithelial-to-mesenchymal transition (EMT) of cervical cancer cells via targeting MUC4. Biochem Biophys Res Commun. 2017;485(2):556–562.
   PubMed Web of Science ®Google Scholar
• Lv ZD, Kong B, Liu XP, et al. miR-655 suppresses epithelial-to-mesenchymal transition by targeting Prrx1 in triple-negative breast cancer. J Cell Mol Med. 2016;20(5):864–873.
   PubMed Web of Science ®Google Scholar
• Lv Q, Wang W, Xue J, et al. DEDD interacts with PI3KC3 to activate autophagy and attenuate epithelial-mesenchymal transition in human breast cancer. Cancer Res. 2012;72(13):3238–3250.
   PubMed Web of Science ®Google Scholar
• Lu Y, Xiao L, Liu Y, et al. MIR517C inhibits autophagy and the epithelial-to-mesenchymal (-like) transition phenotype in human glioblastoma through KPNA2-dependent disruption of TP53 nuclear translocation. Autophagy. 2015;11(12):2213–2232.
   PubMed Web of Science ®Google Scholar
• Wang J, Liu Y, Li XH, et al. Curcumin protects neuronal cells against status-epilepticus-induced hippocampal damage through induction of autophagy and inhibition of necroptosis. Can J Physiol Pharmacol. 2017;95(5):501–509.
   PubMed Web of Science ®Google Scholar
• Tanida I, Ueno T, Kominami E. LC3 and Autophagy. Methods Mol Biol. 2008;445:77–88.
   PubMedGoogle Scholar
• Cufi S, Vazquez-Martin A, Oliveras-Ferraros C, et al. Autophagy positively regulates the CD44(+) CD24(-/low) breast cancer stem-like phenotype. Cell Cycle. 2011;10(22):3871–3885.
   PubMed Web of Science ®Google Scholar
• Zhang F, Yan T, Guo W, et al. Novel oncogene COPS3 interacts with Beclin1 and Raf-1 to regulate metastasis of osteosarcoma through autophagy. J Exp Clin Cancer Res. 2018;37(1):135.
   PubMedGoogle Scholar